JHLT: The Podcast returns for July with a paper entitled "Comparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: Results from the Trifecta-Heart study," available online now and in the July print issue of JHLT.

Today's guests are first author Katelynn S. Madill-Thomsen, PhD and senior author Philip F. Halloran, MD, PhD, both from the Alberta Transplant Applied Genomics Center in Canada.

In the episode, the authors and editors discuss:

• Striking similarities—and key differences—in the DSA-negative and DSA-positive groups
• Changes to clinical practice based on the findings, including innovations from the kidney transplant community
• Future studies, including tools and therapies that could be explored for improved clinical outcomes

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

For the first time, JHLT: The Podcast welcomes a patient onto the podcast. The Digital Media Editors are pleased to welcome heart transplant recipient and patient advocate Payton Herres for a discussion about her recent perspective piece in JHLT.

In this compelling, moving discussion, Payton shares:

• Her treatment story—from her congenital diagnoses to her life-changing transplant—and her donor's story
• The difference between coverage and access—and how FDA labeling affected her access to an important component of her care
• What she wishes clinicians understood about long-term care of transplant patients

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On JHLT: The Podcast, we kick off June with a paper entitled "Serial assessment of modified Society for Cardiovascular Angiography and Interventions SHOCK classification in post-cardiotomy patients," which is available online now and in the June issue of JHLT.

Today's guests are first author Ufuk Baldan, MD and senior author Patrick Klein, MD, PhD, both of the Amsterdam University Medical Center in the Netherlands.

We discuss:

• The heterogeneous nature of post-cardiotomy shock and challenges to treat
• Should serial assessments become standardized post-cardiac surgery?
• Does SCAI staging overestimate risk—and how do we interpret the stages we observe immediately post-op?
• What's next for this line of research?

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

On this special episode of JHLT: The Podcast, the Digital Media Editors take a look back at the exciting science that was on display at ISHLT2026, the ISHLT 46th Annual Meeting & Scientific Sessions.

Topics include:

• Artificial intelligence and machine learning in transplantation, especially in assessing donor lungs and EVLP
• Cardiogenic Shock science at ISHLT2026, including a well-attended, all-new Academy
• The re-launch of the ISHLT International Thoracic Organ Transplant Registry, and the recent report in JHLT

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast starts May with an important ten-year update to a keystone document—the "ISHLT Consensus Conference on Graft Dysfunction within the First 72 Hours after Heart Transplantation." The consensus summary—and a perspective piece by the authors—appears in the May issue of JHLT, and is available in full on ISHLT.org.

The podcast is happy to host conference leader and first author Jon Kobashigawa, MD, Cedars-Sinai in Los Angeles, to talk about the consensus document, the conference, and PGD.

The conversation includes discussion of:

• Why the document needed updating and how consensus was achieved
• The revised severity scale for PGD and the omission of the vasoactive-inotropic score
• Changes from the old document, including:
  • Newer predictors of PGD
  • The latest donor preservation devices
  • Updated treatment approaches

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

In this episode, JHLT: The Podcast highlights a special issue of the Journal of Heart and Lung Transplantation that's just been released. The issue focuses on innovations in Device Therapies, and was edited by JHLT Deputy Editor Manreet Kanwar, MD, FACC, of the University of Chicago. Dr. Kanwar joins Digital Media Editor Van-Khue Ton, MD, PhD for a discussion about the special issue.

The discussion explores:

• The importance of discussing device therapies in the advanced heart and lung failure communities
• The most anticipated device therapies in the pipeline for clinicians and patients to consider
• The impact of publishing in JHLT

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Read the special issue on ScienceDirect or at the Journal website.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast kicks off April with a discussion of the paper, "Lung Cancer After Lung Transplantation: Early Detection and Curative Surgery Drive Long-Term Survival," which appears in the April issue of JHLT.

Senior author Pauline Pradère, MD, of Hôpital Marie Lannelongue in Paris, joins the episode to talk about the paper.

The conversation includes discussion of:

• The overall survival of patients who develop lung cancer after lung transplant—and the key differences between the cohort of patients who developed cancer versus the patients who did not
• Managing lung cancer in transplant recipients
• Immunosuppression in these patients, and other potential changes to clinical practice derived from the study

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast continues a themed month on HIV infection in solid organ transplant, building on our last episode's exploration from Dr. Saeed at Montefiore in New York.

Our guest this episode is infectious diseases expert Cameron Wolfe, MD, Professor of Medicine at Duke University Medical Center. He joined us while on sabbatical with his family in Brisbane Australia for a conversation about how transplant centers now consider HIV infection, including transplant recipients who are HIV positive.

The discussion explores:

• How the HOPE Act of 2013 changed practice in the United States, and how other countries have handled HIV transplantation regulations
• Immunosuppresion, antiviral therapy, and opportunistic infection in HIV+ transplant recipients
• Whether organ-specific surveillance changes in HIV+ patients
• The ethics of using organs from HIV+ donors and ensuring HIV+ patients are treated equitably

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

This month on JHLT: The Podcast, the Digital Media Editors host two themed discussions around HIV in solid organ transplantation. The conversation begins with a discussion of the paper, "Early experience in heart transplantation utilizing donors with HIV," which appears in the March issue of JHLT.

First author Omar Saeed, MD, MSc, of the Division of Cardiology at Montefiore Medical Center in New York, NY USA, joins the episode.

The conversation includes discussion of:

• The ethics and evolution of the Montefiore program's transplant eligibility and criteria
• The role of the HOPE Act in the changes to the program
• Superinfection, viral strain analysis, and informed consent of organ recipients
• Long-term patient follow upsa nd how other centers can begin this research

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Return later this month for a broader conversation with an infectious diseases expert about HIV in transplantation.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

JHLT: The Podcast returns with an episode for our heart transplant colleagues, discussing the paper, "Barriers and opportunities in donation after circulatory death heart transplantation," from the February issue of JHLT.

Featured on this episode is first author, Katherine G. Phillips, MD, of the Department of Cardiothoracic Surgery at NYU Langone, and co-author, Brian Wayda, MD, from the Division of Cardiology at NYU Langone.

The discussion explores:

• Geographic variability on DCD heart utilization—why it happens and how to address
• Concerns around donor progression to circulatory arrest after life support withdrawal
• The volume of DCD hearts not utilized each year—and the gap between those successfully transplanted

For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.